Immunic

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.

About IMUX

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. 

CEO
Daniel Vitt
CEODaniel Vitt
Employees
55
Employees55
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2003
Founded2003
Employees
55
Employees55

IMUX Key Statistics

Market cap
103.92M
Market cap103.92M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
180.18K
Average volume180.18K
High today
$3.64
High today$3.64
Low today
$3.30
Low today$3.30
Open price
$3.48
Open price$3.48
Volume
185.13K
Volume185.13K
52 Week high
$14.50
52 Week high$14.50
52 Week low
$2.52
52 Week low$2.52

IMUX Earnings

-$1.63
-$1.09
-$0.54
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.